Učitavanje...
Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
Choosing antithrombotic regimens for patients with atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) with stent placement is challenging. Until recently, the guidelines recommended warfarin-based triple therapy, which causes frequent major bleeding events in up to 12% o...
Spremljeno u:
| Izdano u: | J Lipid Atheroscler |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Korean Society of Lipidology and Atherosclerosis
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7379079/ https://ncbi.nlm.nih.gov/pubmed/32821695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12997/jla.2019.8.1.8 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|